Overview
Today’s scan produced 10 continuation breakout signals against a Cautious-Bearish regime backdrop — breadth sits at just 34.0% above the 40-day SMA with bearish sentiment readings on both technical and fundamental gauges. In this environment, volume conviction matters more than raw price change, and only three of today’s ten candidates (ELV, AAPL, FCX) show RVOL above 1.5, so we’re treating this as a selective day rather than a broad breakout event.
Quality Score: 3/5 (capped per regime rules). While signal count is healthy, average RVOL across the group is soft (many names print sub-1.0 relative volume), and the regime’s bearish sentiment limits how aggressively these setups should be sized. The saving grace is sector alignment — Health Care/Medical names (ELV, ABBV, WST) make up 30% of today’s list and sit directly in one of the market’s leading sectors (Health Care ATR% +0.6%).
Sector concentration: Diverse overall — Software, Semiconductors, Internet, Building Products, Telecom, and Mining are all represented — but Medical/Health Care is the clear cluster, giving today’s tape a modest defensive-growth tilt rather than a single hot theme.
Top 5 Picks
ELV ($416.54) — Medical / Managed Care
ELV posts the strongest volume signature of the group, up 5.0% on 2.1x RVOL while holding right at a 4h demand zone (404.73–407.99, strength 5.3). ATR%-M of 1.8 confirms expanding volatility in the direction of the move. Health Care is a top-performing sector today, adding conviction to this setup.
| Entry | Stop | Target |
|---|---|---|
| $416.50 | $403.00 (below demand) | $440.00 (into monthly supply) |
Institutional Backing: 3,289 funds holding.
AAPL ($326.57) — Telecom / Consumer Products
AAPL is pressing a tight 4h supply zone just 0.51% overhead (328.22–330.56), backed by 1.7x RVOL and a 3.6% gain. A confirmed break above supply would clear the way toward the next leg, with a well-defined demand shelf below at 313.11–316.17 for risk control.
| Entry | Stop | Target |
|---|---|---|
| $330.60 (breakout) | $320.00 | $345.00 |
Institutional Backing: 8,321 funds — the deepest institutional base in today’s group.
WST ($344.25) — Medical Products
WST is up 2.2% on 1.4x RVOL, holding above a daily demand zone (327.61–336.39, strength 5.2) with a large supply shelf overhead (355.48–386.00). The wide gap between zones offers a favorable risk/reward skew for a continuation move within the Medical sector’s relative strength.
| Entry | Stop | Target |
|---|---|---|
| $344.25 | $327.00 | $355.50 |
Institutional Backing: 2,159 funds (INST bucket).
ABBV ($255.00) — Pharmaceuticals
ABBV climbed 1.6% and sits just below daily supply (261.72–262.97). RVOL is neutral at 1.0, but the setup benefits from Health Care’s sector leadership and a deep institutional book. A clean push through supply would confirm the continuation thesis.
| Entry | Stop | Target |
|---|---|---|
| $263.00 (breakout) | $250.00 | $272.00 |
Institutional Backing: 5,005 funds (5K bucket).
FCX ($71.21) — Mining / Metal Ores
FCX pulled back 6.6% but landed squarely in a high-strength weekly demand zone (65.57–69.74, strength 7.3) on elevated 1.6x RVOL — a classic pullback-to-support continuation setup within a name up over 100% from its 52-week low. Supply sits tight overhead at 73.57–74.06.
| Entry | Stop | Target |
|---|---|---|
| $71.21 | $65.00 | $74.00 |
Institutional Backing: 2,895 funds (INST bucket).
Honorable Mentions
- RDDT ($155.34): Strong 6.1% move but RVOL only 0.8 and price sits between zones — needs volume confirmation.
- WSO ($310.90): Sitting at demand with a tight 30m zone, but RVOL of 0.8 keeps this on watch-only status.
- TSM ($428.03): At supply with a -1.7% daily change; wait for reclaim before treating as continuation.
- MSFT ($492.44): Elevated ATR%-M (4.1) is notable, but RVOL of 0.7 is too thin to confirm.
- APP ($314.49): At supply with negative ATR%-M (-3.4); momentum is fading into resistance.
Strategy Summary
Today’s continuation setups are moderate quality — the Cautious-Bearish regime caps upside conviction, and roughly half the signal list shows sub-1.0 RVOL, which tempers the “strong breakout day” narrative despite the 10-signal count. The standout theme is Health Care/Medical strength (ELV, ABBV, WST), consistent with the sector’s leadership in today’s ATR% rankings, while AAPL’s institutional depth and FCX’s high-strength demand zone round out the actionable list. Given the regime backdrop, favor tighter stops, partial sizing, and confirmation of volume before committing full risk on any single name.